Search results for “Follicular lymphoma grade II” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 337 patents, we discovered top 55 key players by total patent application. Epizyme, Inc., Genentech, Inc., Bayer Pharma AG are dominant in this area. They take 25.82% of the total patent filing.
Epizyme, Inc.
Massachusetts, United States
Patent: 31
Genentech, Inc.
California, United States
Patent: 28
Bayer Pharma AG
Berlin, Germany
Patent: 28
AbbVie, Inc.
Illinois, United States
Patent: 19
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 19
Biogen MA, Inc.
Massachusetts, United States
Patent: 18
Portola Pharamceuticals, Inc.
California, United States
Patent: 16
Genmab A/S
Hovedstaden, Denmark
Patent: 14
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Janssen Biotech
Belgium
Patent: 12
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
STARTUP
BostonGene Corp.
Massachusetts, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 131 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing Genentech, Inc., Genmab A/S, Janssen Biotech take 34.35% of patent filing during this period.
Genentech, Inc.
California, United States
Patent: 19
Genmab A/S
Hovedstaden, Denmark
Patent: 14
Janssen Biotech
Belgium
Patent: 12
MEI Pharma, Inc.
California, United States
Patent: 11
Portola Pharamceuticals, Inc.
California, United States
Patent: 9
Novartis AG
Basel-Stadt, Switzerland
Patent: 8
Kite Pharma, Inc.
California, United States
Patent: 8
Juno Therapeutics, Inc.
Washington, United States
Patent: 7
Adagene AG
Switzerland
Patent: 7
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 131 patents in last 5 years, we discover 19 new entrants. Genmab A/S, Janssen Biotech, MEI Pharma, Inc. are the most active new entrants in this area.
Genmab A/S
Hovedstaden, Denmark
Patent: 14
Janssen Biotech
Belgium
Patent: 12
MEI Pharma, Inc.
California, United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 8
Kite Pharma, Inc.
California, United States
Patent: 8
Adagene AG
Switzerland
Patent: 7
Juno Therapeutics, Inc.
Washington, United States
Patent: 7
Masaryk University
Czechia
Patent: 3
Fakultni Nemocnice Brno
Czechia
Patent: 3
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 72 patents, we discovered top 15 universities and scientific research institutions by total patent application. New York University, Dalian Medical University, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 56.94% of the total patent filing.
New York University
New York, United States
Patent: 18
Dalian Medical University
Liaoning Sheng, China
Patent: 6
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 5
Nagoya City University
Aichi-ken, Japan
Patent: 5
Masaryk University
Czechia
Patent: 3
Université d'Aix-Marseille
France
Patent: 3
Cornell University
New York, United States
Patent: 2
Imperial College London
United Kingdom
Patent: 2
The Curators of the University of Missouri
Missouri, United States
Patent: 2
University of Washington
Washington, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: